Loading clinical trials...

Analgesic Efficacy of Sacral Neuromodulation for Pelvic Cancer Pain: A Preliminary Report | Clinical Trials | Clareo Health

UNKNOWNNA

Analgesic Efficacy of Sacral Neuromodulation for Pelvic Cancer Pain: A Preliminary Report

Does Sacral Neuromodulation Relieve Chronic Pelvic Cancer Pain, Compared With Medical Treatment?

NCT04549818•Assiut University

View on ClinicalTrials.gov

Summary

in this trial, we will test the analgesic efficacy of sacral neuromodulation for patients with pelvic cancer, complaining of chronic pelvic pain in comparison to medical treatment.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age, 18-70
•Pain localized to the pelvic and perineal region
•The pain is due to pelvic cancer or chronic pelvic pain after pelvic surgery for cancer
•The intensity of pain assessed by VAS (visual analogue pain scale) \> 7
•Importantly, the included participants should gain \> 50% reduction of their pain in response to sacral roots block, S2,3 and 4 with bupivacaine 0.5%, 2 ml for each root

Exclusion Criteria

•Coagulopathy
•Infection at site of maneuver
•Abnormal Psychological behavior that interfere with integrity of obtained data

Key Dates

Start Date

September 10, 2020

Primary Completion Date

September 10, 2021

Completion Date

December 10, 2021

Last Updated

September 16, 2020

Enrollment

ESTIMATED participants

Conditions

Chronic Pain

Interventions

sacral neuromodulation

DEVICE

Optimization of NIBS for Treatment of Addiction

NCT04379115

Opioid-use DisorderChronic Pain

View study

RECRUITINGNA

VR Mindfulness Training for Veterans With SCI

NCT06587607

Spinal Cord InjuryChronic Pain

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 16, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Analgesic Efficacy of Sacral Neuromodulation for Pelvic Cancer Pain: A Preliminary Report

Inclusion Criteria

Exclusion Criteria

Optimization of NIBS for Treatment of Addiction

VR Mindfulness Training for Veterans With SCI

CIH Stepped Care for Co-occurring Chronic Pain and PTSD

Personalized High-Definition tDCS Protocols for Chronic Pain Treatment

Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia

Cryoneurolysis Prior to Total Knee Arthroplasty (CRYO-TKA Trial)